Systemic lupus erythematosus (SLE) is the prototypic systemic autoimmune disease. The
clinical features are well-known: production of autoantibodies, immune complex–mediated end…

Systemic lupus erythematosus (SLE) is a heterogeneous and complex group of disorders of
unclear cause. The complexity arises from three major sources (genes, environment, and …

… The main purposes of renal biopsy in patients with systemic lupus erythematosus are to
confirm the diagnosis of lupus nephritis, to assess disease activity and/or chronicity, guide …

… to determine the characteristics of the clinical manifestations, laboratory findings and
prognostic impact of the thrombocytopenia patients with systemic lupus erythematosus (SLE). The …

… Systemic lupus erythematosus (SLE) is an auto immune disorder mediated by the
immune complex and characterised by its protean clinical mani festation and multisystemic …

… of platelets is a common clinical manifestation in systemic lupus erythematosus (SLE),
ranging … Apart from diverse aetiologies in lupus thrombocytopenia, its clinical implications and …

… Thrombocytopenia is a common clinical manifestation and one of the hematological criteria
of systemic lupus erythematosus (SLE) according to the American College of Rheumatology (…

… BAFF overexpression has been commonly detected among patients with Systemic Lupus
Erythematosus (SLE) and seems to be strongly involved in the pathogenesis of the disease. …

… in SLE management, outlining recent developments and clinical implications for patients. …
for lupus disease control and further therapies yet to emerge. The clinical implications of …

… This review also highlights the clinical implications of tolDC-based therapy for SLE treatment,
examines the current clinical therapeutics in patients with SLE, which can generate tolDC …